Expression of interleukin-32 in bone marrow of patients with myeloma and its prognostic significance

doi:10.12998/wjcc.v7.i24.4234

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 24

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5216)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-4) series.

Item

Count

PDF

270

WORD

149

HTML

2561

Figures (1-3)

154

Tables (1-4)

208

Sum=3342

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

692

Download

1182

Sum=1874

Dec 26, 2019 (publication date) through Jul 22, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Clin Cases. Dec 26, 2019; 7(24): 4234-4244
Published online Dec 26, 2019. doi: 10.12998/wjcc.v7.i24.4234

Full Size Figure Download Figure

Figure 1 Receiver operating characteristic curve analysis of interleukin-32 in evaluating patient survival status. AUC: Area under curve.

Citation: Wang G, Ning FY, Wang JH, Yan HM, Kong HW, Zhang YT, Shen Q. Expression of interleukin-32 in bone marrow of patients with myeloma and its prognostic significance. World J Clin Cases 2019; 7(24): 4234-4244
URL: https://www.wjgnet.com/2307-8960/full/v7/i24/4234.htm
DOI: https://dx.doi.org/10.12998/wjcc.v7.i24.4234